Mechanistically, F. nucleatum targets the TLR4 and MYD88 innate immune signaling pathways, along with specific microRNAs, to activate the autophagy pathway, thereby altering the chemotherapeutic response in CRC. The gene discussed is TLR4; the disease is colorectal carcinoma.